Gao et al. demonstrated that the CD63+ CAF subtype contributes to tamoxifen resistance by releasing exosomal miR-22, which leads to the downregulation of ERα and PTEN expression in breast cancer[21]. Here, ESR1 is linked to breast carcinoma.